These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis.
    Author: Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM.
    Journal: ANNA J; 1991 Jun; 18(3):263-7, 329. PubMed ID: 2064452.
    Abstract:
    Trisodium citrate was used as a regional anticoagulant on 24 patients on continuous arteriovenous hemodialysis (CAVHD), obviating the need for systemic heparinization. Principles of CAVHD, potential complications, and nursing responsibilities are addressed. Clearances, blood flow rate, ultrafiltration and filter patency compare favorably with heparin CAVHD. Citrate anticoagulated CAVHD avoids heparin-associated complications in the critically ill uremic patient.
    [Abstract] [Full Text] [Related] [New Search]